Publication | Closed Access

Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin

Genome-wide Association StudyThrombosisImmunologyGenetic EpidemiologyWarfarin PharmacogenomicsPlatelet AntagonistExtreme-discordant-phenotype MethodologyAnticoagulantPharmacogenomicsPharmacotherapyPublic HealthSystems BiologyMedicineBioinformaticsEpidemiologyStable Anticoagulation